Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Clin Breast Cancer. 2020 Aug 13;21(1):e102–e111. doi: 10.1016/j.clbc.2020.08.005

Table 2.

Summary of Reported Stiffness Parameters of Normal and Abnormal Breast Tissue

Author Year No. Patients (No. lesions) Vibration Frequency, Hz Fibroadenoma/Benign Lesions Benign Fatty Tissue Benign Fibrog丨andular Tissue Malignant Tissue Reported P Values
Bishop 1998 1 (N/A) 50 N/A N/A c: 0.68 ± 0.16 m/s
α: 1.6 ± 0.2 nepers/λ
N/A N/A
Lawrence 1998 9 (N/A) 50–200 N/A fat: 0.43 ± 0.07 kPa FGT: 2.45 ± 0.2 kPa N/A N/A
Sinkus 2000 1 (1) 60 N/A N/A IEI: 0.5–1 kPa IEI: 3.5 kPa N/A
Plewes 2000 1 (N/A) N/R N/A SNR 16 SNR 10 N/A N/A
Lorenzen 2001 3 (4) 65 N/A N/A N/A N/A N/A
Lorenzen 2002 35 (20) 65 Median Gd = 7 kPa; range, 2–8 kPa Median elasticity = 2 kPa; range, 0.5–4 kPa FGT adjacent to BC: median Gd = 2.5
kPa; range, 1–7 kPa stiff FGT: median
Gd = 7 kPa; range, 3–15 kPa
BC: median = 15.9 kPa;
range, 8–28 kPa
BC vs. FGT: P < .001
BC vs. fatty tissue: P < .001
BC vs. benign lesions: P = .0012
McKnight 2002 12 (6) 75–300 N/A Volunteer: 3.3 ± 1.9 kPa Patient: mean = 8 kPa; range, 4–16 kPa Volunteer: 7.5 ± 3.6 kPa mean Gd = 33 kPa; range, 18–94 kPa BC vs. fatty tissue: P < .05
Lorenzen 2003 5 (N/a) 65 N/A N/A N/A N/A N/A
Van Houten 2003 5 (N/A) 100 N/A E: 17.1–23.5 kPa; λ: 41–29 kPa; ν: 0.35–0.41 μ: 9.0–10.8 kPa; E: 24.3–30.3 kPa; λ: 44–57 kPa; ν: 0.39–0.40 N/A N/A
Sinkus 2005 15 (15) 65 μ 1.3 ± 0.7 kPa, ς 2.1 ± 1.4 Pa s N/A μ 0.87 ± 0.15 kPa; ς 0.55 ± 0.12 Pa s μ 2.9 ± 0.3 kPa;
ς 2.4 ± 1.7 Pas
BC vs. FA: μ (P < .001); ς N/R BC vs. FGT: μ (P < . 001); ς (P < .02)
Sinkus 2005 2 (2) 65 FA: μ 1.3 ± 0.7 kPa/ς 2.1 ± 1.4 Pa s mastopathy: μ 1.2 ± 0.4 kPa/ς 0.8 ± 0.3 Pa s N/A FGT: μ 0.87 ± 0.15 kPa; ς 0.55 ± 0.12 Pa s BC: μ 2.9 ± 0.3 kPa; ς 2.4 ± 1.7 Pa s BC vs. FA (μ): P < .001 BC vs FGT (μ): P < .000 01
Xydeas 2005 20 (17) 65 μ 1.4 ± 0.5 kPa; ς 1.7 ± 0,8 Pa s N/A FCC: μ 1.7 ± 0.8 kPa; ς 1.7 ± 0.9 Pa s
FGT: μ 1.2 ± 0.2 kPa; ς 1.0 ± 0.3 Pa s
μ 3.1 ± 0.7 kPa;
ς 2.1 ± 1.2 Pa s
N/A
Sinkus 2007 68 (68) 85 Gd 23.0 ± 1.2 kPa;
Gl 3.6 ± 1.2 kPa
Gd 6.6 ± 0.1 kPa; Gl 0.30 ± 0.1 kPa Gd 12.0 ± 0.6 kPa; Gl 0.73 ± 0.21 kPa Gd 17.2 ± 1.7 kPa;
Gl 3.8 ± 1.1 kPa
N/A
Siegmann 2010 57 (57) 85 N/A N/A N/A N/A N/A
Hawley 2016 22 (N/A) 60 N/A N/A FGT type A: 0.83 ± 0.11; FGT type B: 0.85 ± 0.11 kPa; FGT type C: 0.92 ± 0.13; FGT type D: 0.96 ± 0.13 kPa N/A N/A
Balleyguier 2018 43 (43) 37.5 Gl 0.33 kPa (range = 0.1–0.97 kPa); y = 0.35 (range = 0.19–0.62) N/A N/A IDC: Gl 0.75 kPa (range = 0.28–2.58 kPa); y = 0.68 (range = 0.47–0.9) ILC: Gl 0.57 kPa (range = 0.38–1.04); y = 0.67 (range = 0.57–0.84) N/A

Abbreviations: BC = breast cancer; c = shear wave velocity; E = Young’s modulus; |E| = isotropic elasticity; FA = fibroadenoma; FGT = fibroglandular tissue; Gd = elasticity; Gl = viscosity; N/A = not available; SNR = signal/noise ratio; y = power law exponent; μ = shear modulus; χ = viscosity; λ = Lamé modulus; ν = Poisson’s ratio; α = attenuation.